ScholarDaily app icon

ScholarDaily

Seven official-source daily briefings in one app.

PubliciOS

ScholarDaily Terms of Use

Last updated: October 13, 2026 · Legal owner: WU HAOTIAN · Support: gosingk@gmail.com

Use of the App

Use ScholarDaily for personal information and research awareness. Every brief is an AI-written plain-language summary of a public record, with a link to that record; summaries can be incomplete or wrong, so read the original before acting on anything. Nothing in ScholarDaily is investment, medical, legal, tax, customs, security, or bidding advice: filing briefs make no buy or sell recommendation, trial and FDA briefs are not a basis for care decisions, and contract-opportunity and customs briefs are not a system of record. ScholarDaily is not affiliated with or endorsed by arXiv, the U.S. Securities and Exchange Commission, NIST, CISA, the U.S. Food and Drug Administration, the National Institutes of Health, the U.S. General Services Administration, U.S. Customs and Border Protection, or any other government agency. Papers, filings, advisories, and notices remain owned by their original authors, publishers, and agencies.

Availability

Each briefing depends on its public source, backend processing, network access, and subscription state. Most briefings publish on U.S. weekdays; the vulnerability and customs briefings can update on any day their source posts new records. A day on which a source publishes nothing new has no new brief, and sources index records on their own schedules, so a brief reports what has become publicly visible rather than the moment an action was decided.

Support

For product or account questions, contact gosingk@gmail.com. These terms are maintained by WU HAOTIAN.